Cargando…

Novel Combination of Mesenchymal Stem Cell-Conditioned Medium with Sorafenib Have Synergistic Antitumor Effect of Hepatocellular Carcinoma Cells

OBJECTIVE: Hepatocellular carcinoma (HCC) is the most common liver malignancy. Sorafenib is the first-line systemic treatment for advanced HCCs. However, due to safety concerns, researchers are now looking for ways to boost the efficacy of the medication. One approach for reducing toxicity is combin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seyhoun, Iman, Hajighasemlou, Saieh, Ai, Jafar, Hosseinzadeh, Faezeh, Mirmoghtadaei, Milad, Seyhoun, Seyed Moein, Parseh, Benyamin, Abdolahi, Shahrokh, Ghazvinian, Zeinab, Shadnoush, Mahdi, Verdi, Javad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	West Asia Organization for Cancer Prevention 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485565/ https://www.ncbi.nlm.nih.gov/pubmed/30678447 http://dx.doi.org/10.31557/APJCP.2019.20.1.263

Ejemplares similares

Sorafenib and Mesenchymal Stem Cell Therapy: A Promising Approach for Treatment of HCC
por: Hajighasemlou, Saieh, et al.
Publicado: (2020)

Combinational immune-cell therapy of natural killer cells and sorafenib for advanced hepatocellular carcinoma: a review
por: Hosseinzadeh, Faezeh, et al.
Publicado: (2018)

Anti‐inflammatory effect of mesenchymal stem cells on hepatocellular carcinoma in the xenograft mice model
por: Hajighasemlou, Saieh, et al.
Publicado: (2022)

Characterization and Validation of Hepatocellular Carcinoma (HCC) Xenograft tumor as a Suitable Liver Cancer Model for Preclinical Mesenchymal Stem Cell Studies
por: Hajighasemlou, Saieh, et al.
Publicado: (2018)

Chemo-immune cell therapy by intratumoral injection of adoptive NK cells with capecitabine in gastric cancer xenograft model
por: Ghazvinian, Zeinab, et al.
Publicado: (2023)

Natural Killer Cell Expansion with Autologous Feeder Layer and Anti-CD3 Antibody for Immune Cell Therapy of Hepatocellular Carcinoma
por: Hosseinzadeh, Faezeh, et al.
Publicado: (2019)

3-Dimensional Model to Study Apoptosis Induction of Activated Natural Killer Cells Conditioned Medium Using Patient-Derived Colorectal Cancer Organoids
por: Parseh, Benyamin, et al.
Publicado: (2022)

Contribution of natural killer cells in innate immunity against colorectal cancer
por: Ghazvinian, Zeinab, et al.
Publicado: (2023)

Adaptive NK Cell Therapy Modulated by Anti-PD-1 Antibody in Gastric Cancer Model
por: Abdolahi, Shahrokh, et al.
Publicado: (2021)

Cell therapy in patients with COVID-19 using Wharton’s jelly mesenchymal stem cells: a phase 1 clinical trial
por: Saleh, Mahshid, et al.
Publicado: (2021)

Perspective of placenta derived mesenchymal stem cells in acute liver failure
por: Saleh, Mahshid, et al.
Publicado: (2020)

Patient-derived xenograft (PDX) models, applications and challenges in cancer research
por: Abdolahi, Shahrokh, et al.
Publicado: (2022)

Therapeutic approach of adipose-derived mesenchymal stem cells in refractory peptic ulcer
por: Saleh, Mahshid, et al.
Publicado: (2021)

Angiogenesis and Its Targeting in Glioblastoma with Focus on Clinical Approaches
por: Daneshimehr, Fatemeh, et al.
Publicado: (2022)

Hopes and opportunities of stem cells from human exfoliated deciduous teeth (SHED) in cartilage tissue regeneration
por: Mahdavi-Jouibari, Forough, et al.
Publicado: (2023)

Immunostimulatory properties and antitumor activities of glucans
por: VANNUCCI, LUCA, et al.
Publicado: (2013)

Sunitinib and Sorafenib Modulating Antitumor Immunity in Hepatocellular Cancer
por: Liu, Dai, et al.
Publicado: (2018)

Synthesis and Antitumor Activity of Triazole-Containing Sorafenib Analogs
por: Ye, Wenjing, et al.
Publicado: (2017)

Design, synthesis, and bioactivity evaluation of antitumor sorafenib analogues
por: Zhou, Shiyang, et al.
Publicado: (2018)

Antitumor effects of regorafenib and sorafenib in preclinical models of hepatocellular carcinoma
por: Kissel, Maria, et al.
Publicado: (2017)

The Study of a Novel Sorafenib Derivative HLC-080 as an Antitumor Agent
por: Tang, Ke, et al.
Publicado: (2014)

Triclosan treatment decreased the antitumor effect of sorafenib on hepatocellular carcinoma cells
por: Wu, Man, et al.
Publicado: (2018)

Synergistic antitumor activity of sorafenib and MG149 in hepatocellular carcinoma cells
por: Moon, Byul, et al.
Publicado: (2022)

Schedule-dependent antitumor effects of 5-fluorouracil combined with sorafenib in hepatocellular carcinoma
por: Deng, Lifen, et al.
Publicado: (2013)

Synergistic Antitumor Effect of Sorafenib in Combination with ATM Inhibitor in Hepatocellular Carcinoma Cells
por: Liu, Jianhua, et al.
Publicado: (2017)

Techno-environmental study on the consequences of carwash wastewater and its management methods
por: Kazembeigi, Farogh, et al.
Publicado: (2023)

The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesothelioma
por: Pignochino, Ymera, et al.
Publicado: (2015)

Broad Transcriptomic Impact of Sorafenib and Its Relation to the Antitumoral Properties in Liver Cancer Cells
por: Contreras, Laura, et al.
Publicado: (2022)

Effects of the Oral Ingestion of Probiotics on Brain Damage in a Transient Model of Focal Cerebral Ischemia in Mice
por: Akhoundzadeh, Kobra, et al.
Publicado: (2018)

Capsaicin exerts synergistic antitumor effect with sorafenib in hepatocellular carcinoma cells through AMPK activation
por: Bort, Alicia, et al.
Publicado: (2017)

Synergistic antitumor effect of a γ-secretase inhibitor PF-03084014 and sorafenib in hepatocellular carcinoma
por: Yang, Xuran, et al.
Publicado: (2018)

In situ treatment of metalworking wastewater by chemical addition-dissolved air flotation coupled with UV, H(2)O(2) & ZnO
por: Mofrad, Mohammad Mehdi Golbini, et al.
Publicado: (2019)

Antitumor activity of sorafenib-incorporated nanoparticles of dextran/poly(dl-lactide-co-glycolide) block copolymer
por: Kim, Do Hyung, et al.
Publicado: (2012)

CXCR2 Inhibition Combined with Sorafenib Improved Antitumor and Antiangiogenic Response in Preclinical Models of Ovarian Cancer
por: Devapatla, Bharat, et al.
Publicado: (2015)

Synergistic antitumor effects of tanshinone IIA and sorafenib or its derivative SC-1 in hepatocellular carcinoma cells
por: Chiu, Chien-Ming, et al.
Publicado: (2018)

Dual-functionalized liposome by co-delivery of paclitaxel with sorafenib for synergistic antitumor efficacy and reversion of multidrug resistance
por: Lei, Meng, et al.
Publicado: (2019)

Attenuation of osteoarthritis progression through intra-articular injection of a combination of synovial membrane-derived MSCs (SMMSCs), platelet-rich plasma (PRP) and conditioned medium (secretome)
por: Nabavizadeh, Sara Sadat, et al.
Publicado: (2022)

Development and characterization of sorafenib-loaded lipid nanocapsules for the treatment of glioblastoma
por: Clavreul, Anne, et al.
Publicado: (2018)

Saliva samples as an alternative for novel coronavirus (COVID-19) diagnosis
por: Alizargar, Javad, et al.
Publicado: (2020)

Short-term exposure to some heavy metals carried with PM(10) and cardiovascular system biomarkers during dust storm
por: Badeenezhad, Ahmad, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_g41rjl0ipk2f98qehk9k4j8rcg